Latest ScinoPharm Taiwan Ltd. Stories

2014-10-15 04:22:14

TAINAN, Oct. 15, 2014 /PRNewswire/ -- ScinoPharm (TWSE:1789) announced that it was named the "Active Pharmaceutical Ingredient (API) Supplier of the Year" at the Global Generics and Biosimilars Awards co-hosted by Generics bulletin and Ark Patent Intelligence. The award recognizes excellent performance across a range of business activities and was won in strong competition against a number of leading Pharmaceutical companies including Dr. Reddy's, Teva, Perrigo, Unichem, etc. The...

2014-06-23 08:29:37

FREMONT, Calif., June 23, 2014 /PRNewswire/ -- ValGenesis, Inc., the market leader in Enterprise Validation Lifecycle Management Solutions (VLMS) today announced that ScinoPharm Taiwan Ltd., a manufacturer of potent compound API and finished drug products, has implemented and successfully gone live with the ValGenesis VLMS 3.0 - Validation Lifecycle Management Solution to manage their validation lifecycle processes. Logo - http://photos.prnewswire.com/prnh/20140623/120440...

2014-06-08 20:21:09

TAINAN, June 8, 2014 /PRNewswire/ -- ScinoPharm Taiwan, Ltd. (TWSE: 1789) specializing in the development and manufacture of active pharmaceutical ingredients, and TaiGen Biotechnology (4157.TW; F*TaiGen) jointly announced today the signing of a manufacturing contract for the clinical supply of the API of Burixafor, a new chemical entity discovered and developed by TaiGen. The API will be manufactured in ScinoPharm's plant in Changshu, China. This cooperation not only demonstrates...

2014-05-09 04:21:47

TAINAN, May 9, 2014 /PRNewswire/ -- ScinoPharm Taiwan, Ltd. (TWSE:1789), a specialty Active Pharmaceutical ingredient (API) company, and Lee's Pharmaceutical Holdings Limited (950.HK) announced the execution of two collaboration agreements today. The two parties will jointly develop and produce Fondaparinux, an anti-thrombotic agent and Travoprost and Bimatoprost, two prostaglandin derivative drugs for treating glaucoma. Capitalizing on the strengths and expertise of the two...

2014-02-14 00:21:19

TAINAN, Feb. 14, 2014 /PRNewswire/ -- ScinoPharm (TWSE:1789) an active pharmaceutical ingredient (API) specialty company, announced unaudited record results for its fiscal year 2013. The company posted a historically high NT$5.088 billion (US$167.6 million) in revenue, up 11% over 2012's record-breaking numbers with after-tax net profits of NT$1.273 billion (US$42.4 million), an increase of 9% compared to the same period in 2012. Profits were also at record highs. After-tax earnings...

Word of the Day
  • Bad luck; misfortune.
  • The smallest amount possible or the most worthless thing.
The word 'ambsace' comes from a Latin word meaning 'both'.